PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DX22FKWNU4556959080!typhoid VAC 25mcg 1s — Dms Pharmaceutical Group Inc

Dms Pharmaceutical Group Inc holds $737.3M across 100,503 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent SPE2DX15D9628. PoP ended Apr 21, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support

Awarding office

Dms Pharmaceutical Group Inc

Recipient

Apr 21, 2022

PoP end

$140K

Obligated

$140K

Potential

325411

NAICS

6515

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Dms Pharmaceutical Group Inc — $90

Contract facts

Federal

Contract numberSPE2DX22FKWNU

Also listed asSPE2DX15D9628-SPE2DX22FKWNU

AgencyDla Troop Support

Awarding officeDla Troop Support

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentDms Pharmaceutical Group Inc

CAGE1UNB0

UEIPX72BSBQTKJ3

NAICS325411

No full NAICS 325411 intel page yet. Browse NAICS intelligence

PSC6515

Parent IDIQ / IDVSPE2DX15D9628

Place of performancePARK RIDGE IL

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startApr 21, 2022

PoP end (current)Apr 21, 2022

Obligated$140K

Current value$140K

Potential value$140K

4556959080!TYPHOID VAC 25MCG 1S is a federal award for Dla Troop Support held by Dms Pharmaceutical Group Inc. Estimated value $140K ($140K obligated). Current period of performance ends Apr 21, 2022. Place of performance: PARK RIDGE IL.

Recompete timing

Public

● Past PoP end (1584 days ago)

Current PoP ended Apr 21, 2022 (1584 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Dms Pharmaceutical Group Inc — $737.3M obligated across 100,503 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($737.3M) · all agencies

Department of Defense (DOD)$737.1M · 100%Department of Veterans Affairs (VA)$193K · 0%

Open full company profile →

Related awards

Same parent · incumbent

SPE2D026F0120

8511978882!OTHER MEDICAL

$248K

Apr 26, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract SPE2DX22FKWNU?

SPE2DX22FKWNU (4556959080!typhoid VAC 25mcg 1s) is a Dla Troop Support award with a potential value of $140K, currently held by Dms Pharmaceutical Group Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2DX22FKWNU?

Dla Troop Support awarded SPE2DX22FKWNU to Dms Pharmaceutical Group Inc (potential $140K).

Who is the incumbent on SPE2DX22FKWNU?

Dms Pharmaceutical Group Inc is the incumbent with $737.3M across 100503 related awards in SCOUT’s public footprint. The current period of performance ends Apr 21, 2022.

When does Dms Pharmaceutical Group Inc’s SPE2DX22FKWNU come up for recompete?

SCOUT tracks a period-of-performance end of Apr 21, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on SPE2DX22FKWNU — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 1, 2026 · refreshed monthlyLatest procurement action Apr 21, 2022